| Literature DB >> 12938531 |
Abstract
Tissue engineering, xenotransplantation, gene and cell therapy and other emerging products and processes are altering the way in which risks can be assessed and are bringing new challenges to product demarcation.Mesh：
Year: 2001 PMID： 12938531
Source DB: PubMed Journal: Med Device Technol ISSN： 1048-6690